|Predictors of exacerbation frequency in chronic obstructive pulmonary disease|
|Yang, Hui1,2; Xiang, Pingchao2; Zhang, Erming2; Guo, Wei′ An2; Shi, Yanwei2; Zhang, Shuo2; Tong, Zhaohui1|
|关键词||Chronic obstructive pulmonary disease Exacerbation Forced expiratory volume Comorbidity Positive pressure ventilation|
|刊名||EUROPEAN JOURNAL OF MEDICAL RESEARCH|
|WOS标题词||Science & Technology|
|类目[WOS]||Medicine, Research & Experimental|
|研究领域[WOS]||Research & Experimental Medicine|
|关键词[WOS]||QUALITY-OF-LIFE ; LUNG-FUNCTION ; COPD ; DECLINE ; FLUTICASONE ; SALMETEROL ; TRIAL|
Background: Exacerbations of chronic obstructive pulmonary disease (COPD) are sporadic, acute worsening of symptoms. Identifying predictors of exacerbation frequency may facilitate medical interventions that reduce exacerbation frequency and severity. The objective of this study was to determine predictors of exacerbation frequency and mortality.
Methods: A total of 227 COPD patients were enrolled in a prospective clinical study between January 2000 and December 2011. Reported exacerbations were recorded for the year preceding enrollment and annually thereafter, and patients were grouped by median annual exacerbation frequency into those experiencing infrequent exacerbations (less than one exacerbation annually) and frequent exacerbations (one or more exacerbation annually). Patients experiencing frequent exacerbations were further divided into those experiencing moderately frequent exacerbations (fewer than two exacerbations per year) and severely frequent exacerbations (two or more exacerbations per year). The rate of clinical relapse and survival was recorded over a 10-year period. The mean of follow-up time was 5.15 years per patient.
Results: For patients experiencing infrequent, moderately frequent, and severely frequent exacerbations, median exacerbations in the year preceding enrollment were 0.0, 0.5, 1.0, respectively, and more frequent exacerbations correlated with lower baseline forced expiratory volume in one second (FEV1) (0.81 L, 0.75 L, and 0.66 L, respectively), higher comorbidity (70.7%, 75.0%, and 89.4%, respectively), and greater NPPV use during hospitalization (16.4%, 35.9% and 51.1%, respectively). FEV1 declined and mortality increased with increasing exacerbation frequency.
Conclusions: Exacerbation frequency can be used to generate discreet patient subpopulations, supporting the hypothesis that multiple COPD phenotypes exist and can be used in patient risk stratification.
|作者单位||1.Capital Med Univ, Beijing Chao Yang Hosp Beijing, Beijing Inst Resp Med, Dept Resp & Crit Care Med, Beijing 100020, Peoples R China|
2.Peking Univ, Shou Gang Hosp, Dept Resp & Crit Care Med, Beijing 100041, Peoples R China
|Yang, Hui,Xiang, Pingchao,Zhang, Erming,et al. Predictors of exacerbation frequency in chronic obstructive pulmonary disease[J]. EUROPEAN JOURNAL OF MEDICAL RESEARCH,2014,19.|
|APA||Yang, Hui.,Xiang, Pingchao.,Zhang, Erming.,Guo, Wei&prime.,An.,...&Tong, Zhaohui.(2014).Predictors of exacerbation frequency in chronic obstructive pulmonary disease.EUROPEAN JOURNAL OF MEDICAL RESEARCH,19.|
|MLA||Yang, Hui,et al."Predictors of exacerbation frequency in chronic obstructive pulmonary disease".EUROPEAN JOURNAL OF MEDICAL RESEARCH 19(2014).|
|10.1186@2047-783X-19（714KB）||期刊论文||出版稿||开放获取||CC BY||浏览 请求全文|